A VAD and Novel High Performance Compact Oxygenator for Long-Term ECMO with Local Anticoagulation
Regional anticoagulant therapy was successfully achieved with a significant difference of activated clotting time between the blood samples from the systemic circulation and those from the ECMO circuit.
Thrombosis of the Ascending Aorta During Mechanical Circulatory Support in a Patient with Cardiogenic Shock
We present the case of a patient who developed cardiogenic shock after percutaneous coronary intervention (PCI) and was supported with intra-aortic balloon counterpulsation and the Levitronix CentriMag short-term mechanical circulatory support.
A Modified Technique for Implantation of the HeartWare™ Left Ventricular Assist Device When Using Bivalirudin Anticoagulation in Patients with Acute Heparin-Induced Thrombocytopenia
We report here a modified surgical strategy for the implantation of the HeartWare™ left ventricular assist device, which avoids prolonged disconnection of the blood-filled device from the systemic blood flow, so that bivalirudin can be safely used as anticoagulant.
Anticoagulation for Cardiac Surgery: Where Are We Today? (EP Video)
Dr. Stephen Bader discusses the use of Thormbate III and its clinical implications (52:40 minutes).
Thrombelastography Change after Bridging to Left Ventricular Assist Device from Extracorporeal Membrane Oxygenation Patients
The cause of coagulopathy is seldom reported; therefore, the current prospective study was designed to compare the coagulation status between patients who received extracorporeal membrane oxygenation (ECMO) and bridged ventricular assist device (VAD) thereafter.
Coagulation Management in Patients Undergoing Mechanical Circulatory Support
The need for anticoagulation and anti-platelet therapy varies widely between different pulsatile and non-pulsatile ventricular-assist devices (VADs) and extracorporeal membrane oxygenation (ECMO) systems.
del Nido Versus Buckberg Cardioplegia in Adult Isolated Valve Surgery
del Nido solution is a non-glucose-based, single-dose cardioplegic solution with few data supporting its safety in adults. We hypothesized that it and Buckberg solution offer myocardial protection of equivalent safety for isolated adult valve surgery.
Clinical Results of Different Myocardial Protection Techniques in Aortic Stenosis
Hypertrophied myocardium is especially vulnerable to ischemic injury. This study aimed to compare the early and late clinical outcomes of three different methods of myocardial protection in patients with aortic stenosis.
ECMO as a Bridge to Decision: Recovery, VAD, or Heart Transplantation
A cohort of 124 consecutive patients received ECMO for refractory cardiogenic shock in our institution.